|
|
Silence Therapeutics Plc - Comparative Business Analysis Snapshot
Business Description
Silence Therapeutics Plc Formerly known as SR Pharma PLC. The Group's principal activity is researching and developing pharmaceutical products. It focuses on Ribonucleic Acid Interference technology, as it can selectively silence genes linked to the onset of disease, thus leading to the creation of a new class of therapeutic products. The Group is developing two products relating to Age-Related Macular Degeneration and Acute Kidney Injury. The Group operates in the United Kingdom and Germany.
Competitor Analysis
This analysis compares Silence Therapeutics Plc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
